Evidence map›Paper›PMID 42626842›Full record

ArticleNucleic acids research2026

Coronavirus NSP14 drives internal m7G modification to rewire host splicing and promote viral replication.

Ensueño Esmeralda Sáenz Altamirano, Chien-Hsin Huang, Yueh-Lin Tsai, Tiffany J Tzeng, Natália Fagundes Borges Teruel, Yoatzin Peñaflor-Téllez, Shruti Chatterjee, Isha Pandey, Neelam Oswal, Y Grace Chen and 5 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Ensueño Esmeralda Sáenz AltamiranoCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.
Chien-Hsin HuangCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.
Yueh-Lin TsaiNew England Biolabs Inc., Beverly, MA 01915, United States.
Tiffany J TzengCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.
Natália Fagundes Borges TeruelCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.
Yoatzin Peñaflor-TéllezCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.ORCID 0009-0006-9494-3748
Shruti ChatterjeeCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.
Isha PandeyCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.
Neelam OswalCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, United States.
Y Grace ChenDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, United States.ORCID 0000-0003-3574-5734
Ching-Wen ChangCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, United States.
Ricardo RajsbaumCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.
Lok-Yin Roy WongCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.ORCID 0000-0002-0727-8289
Ivan R CorrêaNew England Biolabs Inc., Beverly, MA 01915, United States.ORCID 0000-0002-3169-6878
Jack Chun-Chieh HsuCenter for Virus-Host-Innate Immunity, Institute for Infectious and Inflammatory Diseases, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, United States.ORCID 0000-0003-4380-8723

Funding

The Role of the Host Ubiquitin System in Promoting SARS-CoV-2 Replication and PathogenesisR01AI166668 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI RAJSBAUM, RICARDO · 2021 to 2025
$2.6M
Mechanisms of internal m7G modification in RNA metabolismR35GM166427 · NIGMS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Chun Chieh Hsu · 2026 to 2026
$432k
Understanding the Molecular Basis of Translation Inhibition by SARS-CoV-2 NSP14 and its Role in SARS-CoV-2 Immune EvasionK22AI168257 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI HSU, CHUN CHIEH · 2023 to 2024
$266k
NIAID NIH HHS K22 AI168257NIAID NIH HHS R01 AI166668NIGMS NIH HHS R35 GM166427NIH HHS K22AI168257NIH HHS R01AI166668NIH HHS R35GM166427Rutgers Busch BiomedicalRutgers University
6 · The paper itself

Abstract

SARS-CoV-2 manipulates host gene expression through multiple mechanisms, including disruption of RNA processing. Here, we identify a novel function of the viral non-structural protein 14 (NSP14) in inducing N7-methylguanosine (m7G) modification in the internal sequences of host mRNA. We demonstrate that NSP14 catalyzes the conversion of GTP to m7GTP, which is subsequently incorporated into mRNA by RNA polymerase II, resulting in widespread internal m7G modification. This activity is dependent on NSP14's N7-methyltransferase (N7-MTase) domain, and the NSP10-NSP14 interaction increases cellular m7G levels primarily by increasing NSP14 protein abundance. NSP14-induced m7G modification is conserved across alpha-, beta-, and gamma-coronaviruses. Mechanistically, we show that this RNA modification is associated with altered splicing, particularly in genes regulating genome stability, RNA metabolism, and nuclear processes. Importantly, using SARS-CoV-2 infection models, we show that viral replication is associated with increased cellular m7G signal, supporting the relevance of this pathway during infection. Inhibition of NSP14 N7-MTase or RNA polymerase II reduces SARS-CoV-2 replication, consistent with a model in which NSP14-induced m7G modification may contribute to viral replication. Our findings reveal a previously unrecognized epitranscriptomic mechanism and suggest that NSP14-induced m7G modification may contribute to the remodeling of host gene expression during coronavirus infection.

Indexed as

GuanosineHost-Pathogen InteractionsRNA SplicingSARS-CoV-2Viral Nonstructural ProteinsVirus ReplicationAnimalsEpitranscriptomeEpitranscriptomicsExoribonucleasesHEK293 CellsHumansMethyltransferasesRNA, MessengerRNA Methylation7-methylguanosineExoribonucleasesGuanosineMethyltransferasesNSP14 protein, SARS-CoV-2RNA, MessengerViral Nonstructural Proteins

Identifiers

PMID42626842
PMCPMC13494556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.